(Total Views: 223)
Posted On: 08/15/2017 10:36:36 AM
Post# of 72446
Just want to provide some logic:
According to Clinical Trials for Prurisol:
"A subject studied under this clinical protocol will commence with a screening period of up to 4 weeks, a treatment period of 12 weeks, and a follow-up period of 4 weeks ending with an End of Study evaluation."
4+12+4= 20 weeks
From the PR today: "We will also highlight the major events upcoming for us in the fourth quarter, namely anticipated completion of our Phase 2 trials of Brilacidin-OM for oral mucositis and Prurisol for psoriasis"
When I start with 12/31/17 and count back 20 weeks, I get August 13th. To me, this means that ALL 189 participants are at least going through screening.
According to Clinical Trials for Prurisol:
"A subject studied under this clinical protocol will commence with a screening period of up to 4 weeks, a treatment period of 12 weeks, and a follow-up period of 4 weeks ending with an End of Study evaluation."
4+12+4= 20 weeks
From the PR today: "We will also highlight the major events upcoming for us in the fourth quarter, namely anticipated completion of our Phase 2 trials of Brilacidin-OM for oral mucositis and Prurisol for psoriasis"
When I start with 12/31/17 and count back 20 weeks, I get August 13th. To me, this means that ALL 189 participants are at least going through screening.
(3)
(0)
